C-reactive protein (CRP) and IL-6, which are commonly used clinical indicators of inflammation and autoimmune diseases, have been proven to be associated with the occurrence of irAEs in melanoma and non-small cell lung cancer patients; however, the changes in the levels of these factors in liver cancer patients who experienced irAEs are unclear (35–39). The gene discussed is CRP; the disease is melanoma.